Arcturus Therapeutics(us:ARCT)

9.48

-7.06%

Updated on 2025-04-03

Open:9.59
Close:9.48
High:9.78
Low:9.18
Prev Close:10.20
Volume:362417.00
Turnover:3.46M
Turnover Ratio:1.34%
Shares:27.12M
MarketCap:257.23M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-302052624895897.07%3244103
2024-03-3119527211799101.10%345480
2023-12-311772542452794.77%365268
2023-09-301632512526394.02%225073
2023-06-301522362026788.89%314163
2023-03-311352330723387.77%254449
2022-12-311352279433185.84%203857
2022-09-301422218388383.74%153766
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Federated Hermes, Inc.469406017.36%-1312-0.03%
2024-06-30Blackrock Inc.26498389.80%-93164-3.40%
2024-06-30Ark Investment Management Llc19649647.27%27531516.29%
2024-06-30Sumitomo Mitsui Trust Holdings, Inc.15630655.78%28654622.45%
2024-06-30Nikko Asset Management Americas, Inc.15630655.78%28654622.45%
2024-06-30State Street Corp15238385.64%-436098-22.25%
2024-06-30Vanguard Group Inc13847445.12%-3150-0.23%
2024-06-30Dimensional Fund Advisors Lp9182223.40%-185598-16.81%
2024-06-30Morgan Stanley7959412.94%-72506-8.35%
2024-06-30Woodline Partners Lp7540232.79%-160341-17.54%

About

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Address:10628 Science Center Drive,Suite 250

Market Movers